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Abstract Using antibodies recognizing the phosphorylation 
state of specific sites, phosphorylation states of tau were moni- 
tored in fetal rat primary cultured neurons. When cultured neu- 
rons were treated with okadaic acid (OA) or calyculin A (CalA) 
at concentrations ufficient to inhibit protein phosphatase 2A 
(PP2A), phosphorylation of Ser-1991Ser-202 (numbered accord- 
ing to the human tau 441) and Ser-235 increased. On the other 
hand, treatment with Ca 2÷ ionophore, A23187, induced 
dephosphorylation of Ser-1991Ser-202, Thr-205, Ser-396 and 
Set-404, and this dephosphorylafion was repressed by inhibitors 
of protein phosphatase 2B (PP2B), cyciosporin A and FK506. 
These results indicate that PP2A and PP2B are differentially 
involved in dephosphorylation of tau in neurons. 
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However, the broad substrate specificity of protein 
phosphatases [20,21] makes it uncertain that these protein 
phosphatases indeed act on tau in vivo. To resolve this ques- 
tion, we used rat primary cultured neurons and examined which 
protein phosphatase d phosphorylates which phosphorylation 
sites of tau. We chose to use cultured neurons because they are 
amenable to treatments with protein phosphatase inhibitors. 
Another advantage ofusing fetal brain neurons was the expres- 
sion of a single tau species, which differ from adult rat brain 
in which complicated expression patterns of alternatively 
spliced isoforms might hinder the observation of phosphoryla- 
tion-dependent electrophoretic mobility shift [22-24]. Finally, 
the use of antibodies that can recognize a single site-specific 
phosphorylation is also a considerable t chnical improvement 
over other systems. We report here our findings that PP2A and 
PP2B are capable of dephosphorylating tau in a site-specific 
and Ca2+-dependent manner. 
1. Introduction 2. Materials and methods 
Tau is a brain-specific, heat-stable microtubule-associated 
protein (MAP) with an ability to promote the assembly of 
tubulin into microtubules [1 3]. Tau is a phosphoprotein a d 
phosphorylation is known to regulate its microtubule polymer- 
ization and stabilization abilities [3-6]. In particular, currently 
phosphorylation f tau has attracted much attention, because 
of the fact that the highly phosphorylated form of tau is a main 
component of the paired helical filaments (PHFs) found in 
Alzheimer's disease brains [7-9]. Although tau protein kinases 
have been extensively studied [10-12], it has become vident 
that phosphorylation of tau is also modulated by protein 
phosphatases. There are several reports on protein 
phosphatases that dephosphorylate tau in vitro [13 19]. Al- 
though there are some contradictions, protein phosphatase 2A 
(PP2A) and 2B (PP2B) have been shown to dephosphorylate 
Alzheimer tau or tau phosphorylated by Ca2+-calmodulin ki-
nase II, cAMP-dependent protein kinase, MAP kinase and 
cdc2 kinase in vitro [13-19]. 
*Corresponding author. Fax: (81) (45) 924 5738. 
Abbreviations: PP1, protein phosphatase 1; PP2A, protein phosphatase 
2A; PP2B, protein phosphatase 2B; CalA, calyculin A; CysA, cy- 
closporin A; OA, okadaic acid; cdk5, cyclin-dependent kinase 5; 
GSK3fl, glycogen synthase kinase 3,8 MAP kinase, mitogen-activated 
protein kinase; PHF, paired helical filament. 
2.1. Chemicals and antibodies 
Okadaic acid and calyculin A were purchased from Wako Chemicals 
(Osaka, Japan). Cyclosporin A and FK506 was provided by Drs. Takao 
Kataoka and Kazuo Nagai (Tokyo Institute of Technology, Tokyo, 
Japan). Ca 2+ ionophore, A23187, was purchased from Sigma (St Louis, 
MO). 
Anti-phospho-Thr-205 (PT205), phospho-rat Ser-235 (PS235), 
phospho-Ser-396 (PS396), and phospho-Ser-404 (PS404) sera were ob- 
tained by immunizing rabbits with phosphorylated peptide conjugated 
with keyhole limpet hemocyanin [25]. Amino acid sequences of these 
antigen peptides were in the following. PT205, C-PGSPGTpPGSRS; 
rat PS235, C-RTPPKSpPSASK; PS396, C-EIVYKSpPVVSG; PS404, 
C-VSGDTSpPRHLS. Here Sp and Tp represent phosphoserine and 
phosphothreonine, respectively. Antihuman tau antibody was gener- 
ously provided by Dr. Yasuo Ihara (University of Tokyo, Tokyo, 
Japan). Anti-Taul antibody was purchased from Sigma. Anti-Taul 
recognizes dephosphorylation at Ser-199/Ser-202. Anti-PT205, antirat 
PS235, anti-PS396 and anti-PS404 recognize phosphorylation at Thr- 
205, Ser-235, Ser-396 and Ser-404, respectively. Antihuman tau is phos- 
phorylation-independent. 
2.2. Cell culture 
Cerebral cortical neurons were prepared from 17- or 18-day-old 
embryonic rat brains. The brains were dissected free of meninges, 
minced in phosphate-buffered saline, and incubated with 0.125% tryp- 
sin and DNase I (Sigma) at 37°C for 15 min. The cortices were disso- 
ciated mechanically with a pipette and plated in polyethylenimine- 
coated tissue culture dishes in Dulbecco's modified Eagle medium and 
Ham's F-12 (1:1) supplemented with 5% newborn calf serum and 5% 
horse serum. Cytosine arabinoside (10 ¢tM) was added to culture me- 
dium 2 days after plating to inhibit proliferation of nonneuronal cells. 
The cultures were fed 3 x a week and used 10~14 days after plating. 
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2.3. Preparation of cel! lysate and bra& extract 
Cultured neurons were homogenized with 5 vols. of 0.1 M MES, pH 
2.8, 0.75 M NaCI, 0.5 mM MgCI2, 1 mM EGTA and 0.1 mM EDTA 
containing 2 mM dithiothreitol, 20 mM NaF, 20 mM fl-glycero- 
phosphate and a protease inhibitor, 0.2 mM Pefabloc SC (Merck, 
Darmstadt, Germany), and immediately boiled for 5 min. After centrif- 
ugation at 100,000 ×g for 30 min, the supernatant fraction was used 
as the heat-stable c ll extract. In some xperiments, cultured neurons 
were directly solubilized in SDS-sample buffer and boiled. Rat brains 
were homogenized in the same buffer used for cultured neurons and 
boiled immediately (within 1 min) after decapitation. After centrifuga- 
tion as described above, the supernatant fraction was used as the heat- 
stable brain extract. 
2.4. SDS-PA GE and immunoblotting 
SDS-polyacrylamide gelelectrophoresis (SDS-PAGE) was carried 
out using an acrylamide concentration of 9.0% [26], Proteins were 
transferred toPVDF membrane (Millipore, Bedford, MA) and reacted 
with antiphosphorylation-dependent antibodies with horse radish per- 
oxidase- or alkaline phosphatase-conjugated antirabbit secondary anti- 
bodies [26, 27]. The dilution of antibodies for immunoblots were the 
following: antihuman tau, 1/1000; anti-Taul, 1/10,000; anti-PT205, 
1/100; antirat PS235, 1/100; anti-PS396, 1/400; anti-PS404, 1/200. 
2.5 Protein concentration determination 
Protein concentration was determined by the procedure of Bradford 
[28], using bovine serum albumin as a standard. 
3. Results 
3.1. Phosphorylation states of tau & fetal rat brains and primary 
cultured neurons 
We examined phosphorylation states of tau in primary cul- 
tured neurons and compared with those of tau in fetal brains 
by immunoblotting with phosphorylation-dependent antibod- 
ies. We focused our study on cdk5 (Ser-202, Thr-205, Ser-235 
and Ser-404) and GSK3fl (Ser-199 and Ser-396) phosphoryla- 
tion sites because cdk5 and GSK3fl have been suggested to be 
the major tau protein kinases in porcine and bovine brain 
extracts [26,29,30]. 
Only a blot of cultured neurons is shown in Fig. 1, because 
exactly identical results were obtained with the brain extract. 
Both brain and cultured neuron tau were composed of two 
species that reacted with the phosphorylation-independent an- 
tibody, antihuman tau (Fig. 1, human tau). Treatment with 
alkaline phosphatase hifted the migration of these two species 
to a lower single band (see Fig. 5, lane 6: the upper band 
indicated by arrowhead isE. coli alkaline phosphatase r acted 
with an secondary antibody), indicating that the original two 
bands observed are isoforms with different phosphorylation 
states. Both bands reacted with anti-PS396 and anti-PS404 an- 
Fig. 1. Western blot analysis of phosphorylation states of tau in fetal 
rat primary cultured neurons. Heat-stable extract of cultured neurons 
were separated on 9% SDS-PAGE, transferred to PVDF membrane, 
and reacted with antihuman tau (Human tau), anti-Taul (Taul), anti- 
rat PS235 (PS235), anti-PS396 (PS396), anti-PS404 (PS404) or anti- 
PT205 (PT205). 
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Fig. 2. Effect of okadaic acid on phosphorylation at Taul site of tau 
in primary cultured neurons. Fetal rat primary cultured neurons treated 
with 100 nM OA for 0, 30, 60 and 180 min were homogenized, boiled 
and their heat-stable supernatants were blotted with antihuman tau and 
anti-Tau 1antibodies. 
tibodies, these antibodies recognize the phosphorylation f Ser- 
396 and Ser-404, respectively, (Fig. 1, PS396 and PS404) in 
almost similar ratio of intensity to those stained with the an- 
tihuman tau antibody. On the other hand, antirat PS235 did not 
react with either of two tau bands (Fig. 1, PS235), although 
upon longer development of the blots a faint reaction could be 
seen (data not shown). These two bands were distinguished by 
anti-PT205 or anti-Taul immunoreactivity; theupper band re- 
acted with anti-PT205 antibody while the lower band reacted 
with anti-Taul antibody (Fig. 1, PT205 and Taul). 
3.2. Involvement of PP2A in dephosphorylation of Ser-235 and 
a portion of Ser- 199/Ser-202 in rat primary cultured neurons 
As shown in Fig. 1, a portion of tau (the lower band) was 
dephosphorylated at the anti-Taul site (Ser-199/Ser-202) in 
contrast o the major tau band, which was phosphorylated. 
Ser-235, which is a favorable phosphorylation site for cdk5 in 
vitro, was largely dephosphorylated (Fig. 1). To determine 
which protein phosphatase was involved in dephosphorylation 
of these sites, cultured neurons were treated with okadaic acid 
(OA). 100 nM OA shifted the electrophoretic mobility of tau 
upward, abolished the reactivity with anti-Taul antibody (Fig. 
2), and generated the antirat PS235 epitope (Fig. 5, lane 2 of 
PS235), indicating that increased phosphorylation f Ser-199/ 
Ser-202 and Ser-235 had occured. The same result was obtained 
with 100 nM calyculin A (CalA) treatment (data not shown). 
CalA is an OA class protein phosphatase inhibitor. 
To determine whether PP1 or PP2A is the phosphatase r - 
sponsible for dephosphorylation at these sites, cultured neu- 
rons were treated with various concentrations of OA or CalA. 
PP1 and PP2A are distinguished by the sensitivity to OA or 
CalA. PP2A is inhibited by similar concentrations of OA and 
CalA, whereas PP1 is about 1000 x more sensitive to CalA than 
OA. The electrophoretic mobility shift and the disappearance 
of the anti-Taul reactivity occurred at 10 nM OA (Fig. 3), 
which inhibited the in vitro dephosphorylation of the anti-Taul 
site in fetal tau by purified PP2A. When cultured neurons were 
treated with 10 nM CalA, similar changes, the electrophoretic 
mobility shift (data not shown) and the disappearance of the 
anti-Taul reactivity (Fig. 3), were obtained. These results ug- 
gested the involvement ofPP2A in the electrophoretic mobility 
shift and the disappearance of the reaction with the anti-Tau 1
antibody (Ser- 199/Ser-202). 
3.3. Involvement of PP2B in dephosphorylation oJtau at Ser- 
396, Ser-404 and putative involvement at Ser-199/Ser-202 
and Thr-205 in Ca: + ionophore-treated cultured neurons 
PP2B has also been reported to dephosphorylate the anti- 
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Fig. 3. Disappearance of anti-Taul immunoreactivity dependent on 
concentrations of okadaic acid (OA) and calyculin A (CalA). Fetal rat 
primary cultured neurons were treated with various concentrations of 
OA or CalA for 60 min. Cell lysates were probed on Western blot with 
anti-Taul antibody (upper panels) and quantitation with densitometry 
was done for the immunoreactive band in lysate of cells treated with 
OA (o) or CalA (e) (lower panel). 
Taul site in vitro [17,18]. To test if this is true in neurons, rat 
primary cultured neurons were treated with inhibitors of PP2B, 
cyclosporin A (CysA) or FK506. These immunosuppressants 
inhibit PP2B through their respective intracellular binding pro- 
teins, cyclophilin and FKBP [31]. 1/IM CysA or 100 nM FK506 
did not show any effect on either the band pattern or the 
reaction with anti-Taul antibody during treatments a long as 
24 h (data not shown), suggesting that PP2B is not the protein 
phosphatase that maintains part of the Ser-199/Ser-202 sites in 
a dephosphorylated state in quiescent cultured neurons. This 
results is in good agreement with a recently published paper in 
which rat brain slice cultures were studied [32]. 
To investigate whether PP2B is capable of dephosphorylat- 
ing tau when neurons are activated, cultured neurons were 
treated with Ca 2+ ionophore (A23187). When 5 pM A23187 was 
added to the culture medium, tau increased its electrophoretic 
mobility and showed with enhanced reactivity to the anti-Taul 
antibody. The band indicated by the arrow showed the same 
mobility as tau that had been dephosphorylated by alkaline 
phosphatase (see Fig. 5, lanes 6 and 7). A downward shift on 
SDS-PAGE suggests that net action of PP2B is prevailing over 
action of Ca-'+-calmodulin-dependent protein kinase on tau in 
Ca 2÷ ionophore-treated neurons. Because proteolytic frag- 
ments appeared over 60 min incubation, most likely due to 
Ca2+-activated protease, the incubation time was limited to 30 
min to minimize proteolysis. This increased mobility shift was 
shown to be due to dephosphorylation by PP2B rather than due 
to protein degradation because this sl~ift was suppressed by 
either CysA or FK506 (Fig. 4). 
Phosphorylation states of Thr-205, Ser-235, Ser-396 and Ser- 
404 after treatment with A23187 and CysA are shown in Fig. 
5 (lanes 3 and 4). Thr-205 was readily dephosphorylated by 
A23187 treatment. Addition of CysA did not inhibit this 
dephosphorylation, suggesting either that Thr-205, as well as 
Ser-199/Ser-202 (indicated by the increased reaction with anti- 
Taul antibody even in the presence of CysA or FK506 as 
shown in Fig. 4), may be very sensitive to PP2B or that other 
phosphatases could be activated under this condition. Ser-235 
remained in the dephosphorylated state (Fig. 5, PS235). Anti- 
PS396 and anti-PS404 did not react with the fastest migrating 
tau band (arrow in lane 7), which showed the same electro- 
phoretic mobility as dephosphorylated tau. Compared with the 
reaction of tau with anti-PS396 and anti-PS404 in A23187- 
treated neurons (Fig. 5, lane 3), the increased reaction in the 
presence of CysA (Fig. 5, lane 4) indicated that Ser-396 and 
Ser-404 are dephosphorylated by PP2B under conditions in 
which intracellular Ca 2+ concentration is elevated. 
4. Discussion 
It has become vident that phosphorylation f tau is modu- 
lated not only by protein kinases but also protein phosphatases. 
PP1, PP2A and PP2B have all been reported to dephospho- 
rylate tau in vitro [13 19]. Because of the broad substrate spec- 
ificity of protein phosphatases [20,21], however, many phos- 
phorylation sites could be artificially dephosphorylated by mul- 
tiple protein phosphatases in vitro. An important question is 
whether these protein phosphatases are, in fact, involved in 
dephosphorylation of tau in vivo. In this paper, using rat fetal 
primary cultured neurons, we demonstrated that phosphoryla- 
tion of tau can be regulated by PP2A and PP2B in site-specific 
and Ca2+-dependent manners. Because the phosphorylation 
states of tau in cultured neurons were the same as those in 
brain, we believe that the same protein phosphatases are acting 
on tau in both brain and cultured neurons. 
A portion of anti-Taul sites (Ser-199/Ser-202) was 
dephosphorylated by PP2A in cultured neurons. Heterogene- 
ous phosphorylation at the anti-Tau 1site might reflect its local- 
ization in neurons as has been shown in rat brains, in which the 
dephosphorylated form is found in axon and the phos- 
phorylated form in the cell body and dendrite [33]. If so, 
A23187 A23187 A23187 
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Fig. 4. Ca 2+ ionophore-induced taudephosphorylation and its inhibi- 
tion by cyclosporin A (CysA) and FK506. Ca -,+ ionophore, A23187 (5 
BM), was added to culture medium of fetal rat primary cultured neu- 
rons. After incubation for 0, 30 and 60 min, cell lysate was prepared 
and subjected for Western blot with antihuman tau and anti-Taul 
antibodies. 1 pM CysA or 0.1 pM FK506 was added to the culture 
medium at the same time of A23187 addition. Cell lysates prepared at 
0 and 30 rain incubation were subjected toWestern blotting with an- 
tihuman and anti-Taul antibodies. Arrows indicate the position of tau 
dephosphorylated with E. coli alkaline phosphatase. 
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Fig. 5. Effect of okadaic acid (OA), A23187 and A23187 plus cy- 
closporin A (CysA) on phosphorylation of tau at Thr-205, Ser-235, 
Ser-396 and Ser-404. Heat-stable extracts were prepared from primary 
cultured neurons (control, lane 1), those treated with 100 nM OA for 
30 min (lane 2), those treated with 5 pM A23187 for 30 min (lane 3) 
and those treated with 5 pM A23187 and 1 ,uM CysA for 30 min (lane 
3). After separation on 9% SDS-PAGE and transfer to PVDF mem- 
brane, tau was probed with anti-PT205, antirat PS235, anti-PS396, and 
anti-PS404, respectively. As reference, blots with antihuman tau anti- 
body are shown in lane 5 (control), lane 6 (tau dephosphorylated with 
E. coli alkaline phosphatase) and lane 7 (tau prepared from cultured 
neurons treated with A23187 for 30 rain). Arrow indicates the 
dephosphorylated tau and arrowhead indicates E. coli alkaline phos- 
phatase. 
PP2A, which is active on tau, should also colocalize with anti- 
Taul reactive tau molecules. Recently, a pool of PP2A has been 
shown to colocalize with microtubules in mammalian cultured 
cells [34]. It is possible that a subset of microtubules with tau 
dephosphorylated at its anti-Taul site associates with PP2A in 
neurons as well as in cultured fibroblasts. 
Ser-235 of Alzheimer tau is reported to be dephosphorylated 
by PP2B but not PP2A in vitro [18]. This is apparently contra- 
dictory to our present result that PP2A is a likely protein 
phosphatase responsible for keeping Ser-235 in the 
unphosphorylated state in cultured primary neurons. Normal 
tau could have different conformation from Alzheimer tau, and 
in this conformation, it could become accessible to PP2A. In 
our study, because Ser-235 was dephosphorylated before the 
treatment with Ca 2+ ionophore, we could not determined 
whether PP2B showed potential to dephosphorylate Ser-235. 
As we have reported, there are OA-sensitive and -insensitive 
Ser-235 phosphatases in bovine brain extracts [26], therefore, 
Ser-235 can be dephosphorylated by several protein 
phosphatases in vitro. 
Ser-396 and Ser-404 have been reported to be dephos- 
phorylated by PP2A in vitro [16 19]. This seemed not 
to be the case in fetal rat cultured neurons, although we can not 
rule out the possibility that, as in the case of the anti-Taul site, 
there is a small fraction of tau whose Ser-396 and Ser-404 are 
dephosphorylated by PP2A. Such tau, if present, would be 
detected by antibodies recognizing the unphosphorylated state 
of Ser-396 or Ser-404. 
In contrast to PP2A, PP2B appeared to dephosphorylate 
most tau phosphorylation sites (Ser-199/Ser-202, Thr-205, Ser- 
396 and Ser-404) when cultured neurons were treated with Ca 2+ 
ionophore (Figs. 4, 5). However, there seemed to be some 
variation in sensitivity to Ca 2+ treatment, depending on phos- 
phorylation sites. Ser-199/Ser-202 and Thr-205 were 
dephosphorylated asily even in the presence of PP2B inhibitor. 
This may indicate the possibility that other protein 
phosphatases are activated by Ca 2+ ionophore treatment or 
that PP2B not completely inhibited by CysA dephosphorylates 
them. On the other hand, Ca 2÷ ionophore-dependent 
dephosphorylation of Ser-396 and Ser-404 was clearly shown 
to be mediated by PP2B, because it was suppressed by CysA 
or FK506. 
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